Daraxonrasib News

The US Food and Drug Administration (FDA) has approved Rasonque (daraxonrasib), a new drug for advanced pancreatic cancer. This approval marks a significant dev

The FDA has granted expedited approval to Daraxonrasib, a new drug designed to block a mutated protein that fuels pancreatic cancer tumor growth.

The FDA has approved daraxonrasib, a new pancreatic cancer drug that extended patients' lives to a median of 13.2 months compared to 6.7 months with chemotherap

A US drug agency has approved daraxonrasib, a breakthrough treatment for pancreatic cancer, which experts are hailing as a significant advancement against one o

The FDA has approved the drug Daraxonrasib, which has shown potential to significantly improve outcomes for pancreatic cancer patients, with clinical trials ind